Frontiers in endocrinology · 2026
Adverse cardio-metabolic risk profile and epicardial adiposity in patients with adrenal adenoma: a cross-sectional study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Niziolek Helena, Just Ivica, Tosin Anna, Baumgartner Clemens, Koldyka Oliver, Körmöczi Konrad, Fellinger Paul, Beiglböck Hannes, Bellach Luise, Domenig Oliver, Zeyda Maximilian, Habisch Hansjörg, Madl Tobias, Luger Anton, Vila Greisa, Trattnig Siegfried, Kautzky-Willer Alexandra, Scherer Thomas, Leutner Michael, Krebs Michael, Krssak Martin, Wolf Peter
Аннотация
BACKGROUND: Mild autonomous cortisol secretion (MACS) is associated with an increased cardiovascular mortality, but even patients with non-functioning adrenal adenoma (NFA) might be at risk for cardio-metabolic comorbidities compared to a control group with absence of an adrenal tumor (CON).
MATERIAL AND METHODS: Seventyfour individuals were included in cross-sectional analysis [MACS: n=25(84% females), age: 63(55-67)years, BMI:27.00(24.20-30.50)kg/m2; NFA: n=25(84%females), age: 61(54-68)years, BMI:28.50(27.50-32.20)kg/m2 and CON: n=24 (75%females), age: 58 (51-64)years, BMI: 27.39(22.03-30.17) kg/m2]. Visceral and ectopic fat stores, as well as heart function were assessed by magnetic resonance imaging and spectroscopy. Blood pressure was measured by standardized protocols. Blood was drawn in the fasting state and during an oral glucose tolerance test to assess glucose and lipid metabolism.
RESULTS: The prevalence of hypertension (MACS:84% vs NFA:76% vs CON: 43.5%), dyslipidemia (MACS:96% vs NFA:80% vs CON:62.5%) and prediabetes (MACS:56% vs. NFA:72% vs CON:29.2%) was significantly different between the groups. Markers of glucose metabolism were worse in MACS and best in CON (HbA1c: 5.70 (5.40-5.90)% vs 5.50 (5.40-5.80)% vs 5.40 (5.27-5.60)%, p=0.043); HOMA_IR:2.91(2.19-4.15) vs 2.55 (1.57- 4.97) vs 1.73 (1.00-2.61), p=0.007). epicardial adipose tissue area was highest in MACS patients, followed by NFA, with lowest values in CON (MACS:1159.68 (930.38-1454.11) mm2 vs NFA: 873.23 (638.03-1195.33) mm2 vs CON:672.37 (549.44-890.30) mm2, p<0.001). No relevant between-group-differences in cardiac morphology, intramyocardial fat or intrahepatic fat were observed.
CONCLUSIONS: In this exploratory study, MACS was associated with epicardial adiposity and an adverse cardio-metabolic risk profile.
MATERIAL AND METHODS: Seventyfour individuals were included in cross-sectional analysis [MACS: n=25(84% females), age: 63(55-67)years, BMI:27.00(24.20-30.50)kg/m2; NFA: n=25(84%females), age: 61(54-68)years, BMI:28.50(27.50-32.20)kg/m2 and CON: n=24 (75%females), age: 58 (51-64)years, BMI: 27.39(22.03-30.17) kg/m2]. Visceral and ectopic fat stores, as well as heart function were assessed by magnetic resonance imaging and spectroscopy. Blood pressure was measured by standardized protocols. Blood was drawn in the fasting state and during an oral glucose tolerance test to assess glucose and lipid metabolism.
RESULTS: The prevalence of hypertension (MACS:84% vs NFA:76% vs CON: 43.5%), dyslipidemia (MACS:96% vs NFA:80% vs CON:62.5%) and prediabetes (MACS:56% vs. NFA:72% vs CON:29.2%) was significantly different between the groups. Markers of glucose metabolism were worse in MACS and best in CON (HbA1c: 5.70 (5.40-5.90)% vs 5.50 (5.40-5.80)% vs 5.40 (5.27-5.60)%, p=0.043); HOMA_IR:2.91(2.19-4.15) vs 2.55 (1.57- 4.97) vs 1.73 (1.00-2.61), p=0.007). epicardial adipose tissue area was highest in MACS patients, followed by NFA, with lowest values in CON (MACS:1159.68 (930.38-1454.11) mm2 vs NFA: 873.23 (638.03-1195.33) mm2 vs CON:672.37 (549.44-890.30) mm2, p<0.001). No relevant between-group-differences in cardiac morphology, intramyocardial fat or intrahepatic fat were observed.
CONCLUSIONS: In this exploratory study, MACS was associated with epicardial adiposity and an adverse cardio-metabolic risk profile.